Wound Fluid Extracellular Microvesicles: A Potential Innovative Biomarker for Wound Healing.


Journal

Plastic and reconstructive surgery. Global open
ISSN: 2169-7574
Titre abrégé: Plast Reconstr Surg Glob Open
Pays: United States
ID NLM: 101622231

Informations de publication

Date de publication:
May 2024
Historique:
received: 22 06 2023
accepted: 12 03 2024
medline: 6 5 2024
pubmed: 6 5 2024
entrez: 6 5 2024
Statut: epublish

Résumé

Extracellular vesicles, or microvesicles, are a large family of membrane-bound fluid-filled sacs that cells release into the extracellular environment. Extracellular microvesicles (EMVs) are essential for cell-to-cell communications that promote wound healing. We hypothesize a correlation between the concentration of EMVs in wound fluid and the percentage of wound healing in treated chronic, nonhealing, wounds. A prospective, multicenter, randomized, single-blind clinical trial was conducted to evaluate EMV concentration in relation to wound healing percentages. Wound fluid samples were obtained from 16 patients with stage IV trunk pressure ulcers. Patients were divided equally into two groups: (1) control group on negative pressure wound therapy (NPWT) alone and (2) study group with NPWT plus porcine extracellular matrix dressing. NPWT was replaced two times a week, and porcine extracellular matrix applied once weekly for all subjects. An NPWT canister device, called a wound vacuum-assisted closure, containing wound fluid was collected from each patient every 4 weeks. EMVs were isolated and the concentration measured by nanoparticle tracking analysis. The study group's total healing percentage was around 89% after 12 weeks compared with the control group's percentage of about 52% ( There is a positive correlation between EMV concentration and wound healing percentages. Results propose that the EMVs in wound fluid could serve as a biomarker for healing.

Sections du résumé

Background UNASSIGNED
Extracellular vesicles, or microvesicles, are a large family of membrane-bound fluid-filled sacs that cells release into the extracellular environment. Extracellular microvesicles (EMVs) are essential for cell-to-cell communications that promote wound healing. We hypothesize a correlation between the concentration of EMVs in wound fluid and the percentage of wound healing in treated chronic, nonhealing, wounds. A prospective, multicenter, randomized, single-blind clinical trial was conducted to evaluate EMV concentration in relation to wound healing percentages.
Methods UNASSIGNED
Wound fluid samples were obtained from 16 patients with stage IV trunk pressure ulcers. Patients were divided equally into two groups: (1) control group on negative pressure wound therapy (NPWT) alone and (2) study group with NPWT plus porcine extracellular matrix dressing. NPWT was replaced two times a week, and porcine extracellular matrix applied once weekly for all subjects. An NPWT canister device, called a wound vacuum-assisted closure, containing wound fluid was collected from each patient every 4 weeks. EMVs were isolated and the concentration measured by nanoparticle tracking analysis.
Results UNASSIGNED
The study group's total healing percentage was around 89% after 12 weeks compared with the control group's percentage of about 52% (
Conclusions UNASSIGNED
There is a positive correlation between EMV concentration and wound healing percentages. Results propose that the EMVs in wound fluid could serve as a biomarker for healing.

Identifiants

pubmed: 38706469
doi: 10.1097/GOX.0000000000005781
pii: GOX-D-23-00549
pmc: PMC11068147
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e5781

Informations de copyright

Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.

Déclaration de conflit d'intérêts

The authors have no financial interest to declare in relation to the content of this article.

Auteurs

Walid Mari (W)

From the Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio.

Sara Younes (S)

From the Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio.

Erin Sheehan (E)

College of Medicine and Life Science, University of Toledo, Toledo, Ohio.

Terry L Oroszi (TL)

From the Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio.

David R Cool (DR)

From the Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio.

Rajab Suliman (R)

Department of Information, Operation and Technology Management, John B. and Lillian E. Neff College of Business and Innovation, University of Toledo, Toledo, Ohio.

Richard Simman (R)

Department of Surgery, College of Medicine and Life Science, University of Toledo, Toledo, Ohio.
Wound Care Program, ProMedica Health Network, Jobst Vascular Institute, Toledo, Ohio.

Classifications MeSH